You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 49 No. 3, March 1992 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Therapy for Neurocysticercosis

Comparison Between Albendazole and Praziquantel

Osvaldo Massaiti Takayanagui, MD, PhD; Edymar Jardim, MD, PhD

Arch Neurol. 1992;49(3):290-294.


Abstract

• Praziquantel and albendazole have been recently described as effective drugs for treatment of intraparenchymal brain cysticercosis. We performed a prospective study comparing the efficacy of these drugs. Twenty-two patients were treated with praziquantel and 21 with albendazole. In addition, 16 patients were treated with symptomatic drugs only and used as controls. Treatment was discontinued in two patients receiving praziquantel and one patient receiving albendazole owing to acute decompensation of the increased intracranial pressure, and one of them died. Albendazole and praziquantel were effective when compared with the control group. However, albendazole was significantly more effective than praziquantel in reducing the total number of cysts in the computed tomographic scans (88% vs 50%). Despite these results, however, analysis of clinical course showed a high frequency of neurologic sequelae. Considering the risks and fallibility of anticysticercal therapy, the real solution for this serious disease continues to be prophylaxis of infestation.



Author Affiliations

From the Department of Neurology, Faculty of Medicine of Ribeirão Preto, University of São Paulo, Brazil.


Footnotes

Accepted for publication September 5, 1991.

Reprint requests to Department of Neurology, Faculty of Medicine of Ribeirão Preto, 14049 Ribeirão Preto, São Paulo, Brazil (Dr Takayanagui).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Update on Eosinophilic Meningoencephalitis and Its Clinical Relevance
Graeff-Teixeira et al.
Clin. Microbiol. Rev. 2009;22:322-348.
ABSTRACT | FULL TEXT  

Meta-Analysis: Cysticidal Drugs for Neurocysticercosis: Albendazole and Praziquantel
Del Brutto et al.
ANN INTERN MED 2006;145:43-51.
ABSTRACT | FULL TEXT  

CYSTICERCOSIS IN CHRONIC PSYCHIATRIC INPATIENTS FROM A VENEZUELAN COMMUNITY
MEZA et al.
Am J Trop Med Hyg 2005;73:504-509.
ABSTRACT | FULL TEXT  

Neurocysticercosis in the United States: Review of an important emerging infection
Wallin and Kurtzke
Neurology 2004;63:1559-1564.
ABSTRACT | FULL TEXT  

Topical Review: Neurocysticercosis in Children
Singhi and Singhi
J Child Neurol 2004;19:482-492.
ABSTRACT  

Corticosteroids Versus Albendazole for Treatment of Single Small Enhancing Computed Tomographic Lesions in Children With Neurocysticercosis
Singhi et al.
J Child Neurol 2004;19:323-327.
ABSTRACT  

Current Consensus Guidelines for Treatment of Neurocysticercosis
Garcia et al.
Clin. Microbiol. Rev. 2002;15:747-756.
ABSTRACT | FULL TEXT  

Calcified neurocysticercotic lesions and postsurgery seizure control in temporal lobe epilepsy
Leite et al.
Neurology 2000;55:1485-1491.
ABSTRACT | FULL TEXT  

Clinical Spectrum of 500 Children With Neurocysticercosis and Response to Albendazole Therapy
Singhi et al.
J Child Neurol 2000;15:207-213.
ABSTRACT  

Isolated Echinococcus granulosus hydatid cyst in the CNS with severe reaction to treatment
Chang et al.
Neurology 2000;54:778-778.
FULL TEXT  

Albendazole therapy for subarachnoid cysticerci: clinical and neuroimaging analysis of 17 patients
CARPIO; and DEL BRUTTO
J. Neurol. Neurosurg. Psychiatry 1999;66:411a-412.
FULL TEXT  

Single-day praziquantel versus 1-week albendazole for neurocysticercosis
Del Brutto et al.
Neurology 1999;52:1079-1079.
ABSTRACT | FULL TEXT  

Cysticercosis: Clinical Classification Based on Imaging Studies
Salgado et al.
Arch Intern Med 1997;157:1991-1997.
ABSTRACT  

Is the Course of Neurocysticercosis Modified by Treatment With Anthelmintic Agents?
Del Brutto
Arch Intern Med 1997;157:128-129.
ABSTRACT  

Antiparasitic Drugs
Liu and Weller
NEJM 1996;334:1178-1184.
FULL TEXT  

Medical Treatment for Cysticercosis-Reply
Del Brutto
Arch Neurol 1996;53:295-296.
ABSTRACT  

Neurocysticercosis
Salinas and Garner
Arch Neurol 1996;53:213-213.
ABSTRACT  

Is the Course of Neurocysticercosis Modified by Treatment With Antihelminthic Agents?
Carpio et al.
Arch Intern Med 1995;155:1982-1988.
ABSTRACT  

Medical Treatment of Cysticercosis: Ineffective vs Effective
Garcia and Gilman
Arch Neurol 1995;52:941-941.
ABSTRACT  

Medical Treatment of Cysticercosis--Effective
Del Brutto
Arch Neurol 1995;52:102-104.
ABSTRACT  

Case 8-1993- A 62-Year-Old Cape Verdean Woman with Blurred Vision, Diplopia, a Suprasellar Mass, and Lymphocytic Meningitis
Maguire and Tierney
NEJM 1993;328:566-573.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1992 American Medical Association. All Rights Reserved.